Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials

• Egile Nagusiak: Mahmoud Barbarawi (Egilea), Babikir Kheiri (Egilea), Yazan Zayed (Egilea), Ahmed Aburahma (Egilea), Mohammed Osman (Egilea), Owais Barbarawi (Egilea), Michael Hicks (Egilea), Mustafa Hassan (Egilea), Mohammad L. Alkotob (Egilea), Ghassan Bachuwa (Egilea)
• Formatua: Liburua
• Argitaratua: Greater Baltimore Medical Center, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Drug-eluting stent(DES) implantation is the main interventional treatment for coronary artery disease, and dual antiplatelet therapy(DAPT) remains the gold standard strategy to prevent ischemic events. However, the optimal duration of DAPT after DES implantation remains controversial. Th...